BACKGROUND: We wanted to assess to what extent concentrations of circulating proteins appear to be developmentally regulated, and to what extent such regulation is influenced by intra-uterine inflammation. METHODS: We measured 22 proteins in blood obtained on postnatal days 1, 7, and 14 from 818 children born before the 28th week of gestation for whom we also had information about placenta morphology. RESULTS: Within the narrow gestational age range of this sample, some protein concentrations increase in blood with increasing gestational age. More commonly, the concentrations of inflammation-related proteins decrease with increasing gestational age. We observed this inverse pattern both in children whose placenta was and was not inflamed. CONCLUSIONS/INFERENCES: Regardless of whether or not the placenta is inflamed, the concentrations of inflammation-related proteins in early blood specimens appear to be developmentally regulated with the most common pattern being a decrease with increasing gestational age.
BACKGROUND: We wanted to assess to what extent concentrations of circulating proteins appear to be developmentally regulated, and to what extent such regulation is influenced by intra-uterine inflammation. METHODS: We measured 22 proteins in blood obtained on postnatal days 1, 7, and 14 from 818 children born before the 28th week of gestation for whom we also had information about placenta morphology. RESULTS: Within the narrow gestational age range of this sample, some protein concentrations increase in blood with increasing gestational age. More commonly, the concentrations of inflammation-related proteins decrease with increasing gestational age. We observed this inverse pattern both in children whose placenta was and was not inflamed. CONCLUSIONS/INFERENCES: Regardless of whether or not the placenta is inflamed, the concentrations of inflammation-related proteins in early blood specimens appear to be developmentally regulated with the most common pattern being a decrease with increasing gestational age.
Authors: Christian Schultz; Christina Rott; Petra Temming; Peter Schlenke; Jens C Möller; Peter Bucsky Journal: Pediatr Res Date: 2002-03 Impact factor: 3.756
Authors: B H Yoon; R Romero; J Moon; T Chaiworapongsa; J Espinoza; Y M Kim; S Edwin; J C Kim; N Camacho; E Bujold; R Gomez Journal: J Matern Fetal Neonatal Med Date: 2003-01
Authors: Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott Journal: J Neuroimmune Pharmacol Date: 2017-04-12 Impact factor: 4.147
Authors: J Wells Logan; Elizabeth N Allred; Raina N Fichorova; Stephen Engelke; Olaf Dammann; Alan Leviton Journal: Cytokine Date: 2014-06-02 Impact factor: 3.861
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann Journal: Eur J Paediatr Neurol Date: 2018-01-31 Impact factor: 3.140
Authors: Maheer Faden; Mari Holm; Elizabeth Allred; Raina Fichorova; Olaf Dammann; Alan Leviton Journal: Cytokine Date: 2016-09-24 Impact factor: 3.861
Authors: Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; H Gerry Taylor; Karl K C Kuban Journal: J Child Neurol Date: 2018-01-11 Impact factor: 1.987
Authors: Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Linda J Van Marter; Bhavesh Shah; Camilia R Martin; Michael S D Agus; Alan Leviton Journal: Endocrine Date: 2014-07-06 Impact factor: 3.633
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079